Novartis Trying for Approval of Smoker's Cough Drug | ThirdAge
Links shared publicly online about this topic.
- 0total visits
Novartis Trying for Approval of Smoker's Cough Drug | ThirdAge
View full resource at thirdage.com
Tags: Cough, Cough Medication, Drug, Novartis
Most Recently Shared on September 27, 2011 at 2:40 pm By:
Novartis Trying for Approval of Smoker's Cough Drug http://t.co/it6oFwKP
Novartis to file meningitis vaccine for infants
health.yahoo.net — “Swiss drugmaker Novartis AG wants to file its meningitis vaccine Menveo for use in small infants in the United States and Europe after a late-stage study with children of this age group was successful.” View full resource at health.yahoo.net
Most Recently Shared on October 25, 2010 at 10:40 am By:
Novartis to file meningitis vaccine for infants http://bit.ly/9NSGFK
Novartis Pill For Multiple Sclerosis Wins Approval, But At What Cost? Try $30K/yr. http://n.pr/bsoR4i
npr.org — “Novartis Pill For Multiple Sclerosis Wins Approval, But At What Cost? Try $30K/yr. http://n.pr/bsoR4i” View full resource at npr.org
Most Recently Shared on September 22, 2010 at 6:06 pm By:
Scott Hensley Health Organization
Novartis Pill For Multiple Sclerosis Wins Approval, But At What Cost? Try $30K/yr. http://n.pr/bsoR4i
U.S. seeks more information on Novartis lung drug | Reuters
reuters.com — “ZURICH (Reuters) - U.S. regulators have asked for more information on dosing proposed for a drug from Novartis AG for smoker's lung, or chronic obstructive pulmonary disease, the Swiss group said on Monday. Novartis” View full resource at reuters.com
Most Recently Shared on October 19, 2009 at 4:45 pm By:
Michael Blaiss, MD Doctor, Allergist, and Physician
FDA requests more information from Novartis prior to QAB149 (indacaterol) approval http://bit.ly/3w6bpH (via @Allergy)
Advertisement
